CryoLife to Present at Canaccord Genuity 2015 Medical Technology and Diagnostics Forum

Nov 10, 2015, 17:04 ET from CryoLife, Inc.

ATLANTA, Nov. 10, 2015 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming Canaccord Genuity 2015 Medical Technology and Diagnostics Forum on Thursday, November 19, 2015 at the Westin Grand Central Hotel  in New York.

A live webcast of the Company's presentation is scheduled to begin at 4:00 p.m. ET and will feature an overview of the company by Pat Mackin, President and Chief Executive Officer.  

The live webcast can be accessed through CryoLife's website,, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures.  CryoLife markets and sells products in more than 75 countries worldwide.  For additional information about CryoLife, visit our website,




The Ruth Group

D. Ashley Lee  

Nick Laudico / Zack Kubow

Executive Vice President, Chief Financial Officer           

646-536-7030 / 7020

and Chief Operating Officer

Phone: 770-419-3355


Logo -

SOURCE CryoLife, Inc.